Allarta CEO Dr. Harald Stover is presenting at the European Association for the Study of Diabetes (EASD) 59th Annual Meeting in Hamburg, Germany.
Join him Oct 3rd to learn about the transformative potential of Allarta’s hydrogel technology and our efforts to develop a curative therapy for T1D.
Short Oral Discussion Event A
SO 19 – Transplantation of islet and stem cells today and tomorrow
Tuesday, October 3rd – 12:30 – 13:30
Hydrogel encapsulation can protect functionality of transplanted islets in immunocompetent diabetic animals without immunosuppression